Effects of prednisolone on acute viral myocarditis in mice

The effect of prednisolone on viral myocarditis was studied in BALB/c mice with encephalomyocarditis virus myocarditis. Prednisolone was injected intramuscularly, 10 mg/kg once a day, on days 4 to 13 (experiment 1) and on days 8 to 17 (experiment 2). The control mice in each experiment received injections of distilled water. In experiment 1, myocardial virus titers were maximal but neutralizing antibodies were rarely present on day 4, and viral titers were still elevated and antibody titers were high on day 8. The survival rate of the prednisolone group was significantly lower (p less than 0.05) than that of the control group on days 21, 22 and 23. On day 10, the antibody titers of the prednisolone group were significantly lower (p less than 0.01) than those of the control group, and viral titers of the prednisolone group remained significantly elevated (p less than 0.01), whereas viruses were rarely isolated in the control group. In experiment 2, the survival rate and antibody titers were not significantly different in the prednisolone and control groups. In both experiments, no viruses were isolated on day 14. The present study suggests that corticosteroids given in the early stage aggravate the course of acute viral myocarditis, and that they may not have detrimental effects if given when neutralizing antibody titer levels are high, although they are not expected to have a beneficial effect.

This article has been cited by other articles:

				M. Noutsias, S. Pankuweit, and B. Maisch Chapter 56 Myocarditis, cardiac tamponade, and pericarditis The ESC Textbook of Acute and Intensive Cardiac Care, December 1, 2010; 1(1): med-9780199584314-chapter - med-9780199584314-chapter. [Abstract] [Full Text] [PDF]

				R. E. Eckart, S. S. Love, J. E. Atwood, M. K. Arness, D. C. Cassimatis, C. L. Campbell, S. Y. Boyd, J. G. Murphy, D. L. Swerdlow, L. C. Collins, et al. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination J. Am. Coll. Cardiol., July 7, 2004; 44(1): 201 - 205. [Abstract] [Full Text] [PDF]

				A. Matsumori, Y. Nunokawa, A. Yamaki, K. Yamamoto, M.-W. Hwang, T. Miyamoto, M. Hara, R. Nishio, K. Kitaura-Inenaga, and K. Ono Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-{kappa}B inhibitor Eur J Heart Fail, March 1, 2004; 6(2): 137 - 144. [Abstract] [Full Text] [PDF]

				A. Frustaci, C. Chimenti, F. Calabrese, M. Pieroni, G. Thiene, and A. Maseri Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders Circulation, February 18, 2003; 107(6): 857 - 863. [Abstract] [Full Text] [PDF]

				B. W. Duncan, D. J. Bohn, A. M. Atz, J. W. French, P. C. Laussen, and D. L. Wessel Mechanical circulatory support for the treatment of children with acute fulminant myocarditis J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 440 - 448. [Abstract] [Full Text] [PDF]

				T. Miyamoto, A. Matsumori, M.-W. Hwang, R. Nishio, H. Ito, and S. Sasayama Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1713 - 1718. [Abstract] [Full Text] [PDF]

				K J Lee, B W McCrindle, D J Bohn, G J Wilson, G P Taylor, R M Freedom, J F Smallhorn, and L N Benson Clinical outcomes of acute myocarditis in childhood Heart, August 1, 1999; 82(2): 226 - 233. [Abstract] [Full Text] [PDF]

				C. Kawai From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future Circulation, March 2, 1999; 99(8): 1091 - 1100. [Abstract] [Full Text] [PDF]

				D. M. McNamara, W. D. Rosenblum, K. M. Janosko, M. K. Trost, F. S. Villaneuva, A.J. Demetris, S. Murali, and A. M. Feldman Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy Circulation, June 3, 1997; 95(11): 2476 - 2478. [Abstract] [Full Text]

				W. Z. Wang, A. Matsumori, T. Yamada, T. Shioi, I. Okada, S. Matsui, Y. Sato, H. Suzuki, K. Shiota, and S. Sasayama Beneficial Effects of Amlodipine in a Murine Model of Congestive Heart Failure Induced by Viral Myocarditis: A Possible Mechanism Through Inhibition of Nitric Oxide Production Circulation, January 7, 1997; 95(1): 245 - 251. [Abstract] [Full Text]

				H. Takada, C. Kishimoto, and Y. Hiraoka Therapy With Immunoglobulin Suppresses Myocarditis in a Murine Coxsackievirus B3 Model : Antiviral and Anti-inflammatory Effects Circulation, September 15, 1995; 92(6): 1604 - 1611. [Abstract] [Full Text]

				M. Kodama, S. Zhang, H. Hanawa, M. Saeki, T. Inomata, K. Suzuki, S. Koyama, and A. Shibata Effects of 15-Deoxyspergualin on Experimental Autoimmune Giant Cell Myocarditis of the Rat Circulation, February 15, 1995; 91(4): 1116 - 1122. [Abstract] [Full Text]